Unlock the potential of your healthcare industry equity research and financial analysis
Analyzing the risks and benefits of investments in a pharmaceutical or biotech company requires access to a variety of current data on drug products, pricing, prescription volume, market competition, and more. Medi-Span® Price Rx® from Wolters Kluwer is an efficient, effective resource that offers a broad spectrum of financial institutions' drug pricing data and analytical tools that help enhance equity research and streamline processes that keep you on the leading edge of financial markets.
Let's do a risk-benefit analysis
Access to current drug data can be the difference between quickly and efficiently evaluating an investment opportunity or not being prepared for the moment when it arises. A subscription to Price Rx Pro includes: